ImmunoCellular Therapeutics Ltd (NYSE American:IMUC)

0.265
Delayed Data
As of Feb 23
 +0.0051 / +1.96%
Today’s Change
0.17
Today|||52-Week Range
3.60
-16.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization50.4K47.7K36.2K75.1K
 
 
 
 
 
 
Operating ExpensesGross Income-50.4K-47.7K-36.2K-75.1K
 
 
 
 
 
General Expenses9.4M9.8M15.5M24.0M
 
 
 
 
 
Research And Development5.3M6.0M10.9M19.1M
 
 
 
 
 
Total Operating Expenses9.5M9.9M15.5M24.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.5M-9.9M-15.5M-24.1M
 
 
 
 
 
Extraordinary Credit642.4K529.8K2.9M3.8M
 
 
 
 
 
Interest Expense On Debt----222.8K1.8M
 
 
 
Other Expenses0.00-62.7K0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.8M-9.4M-12.8M-22.1M
 
 
 
 
 
Net Income-8.8M-9.4M-12.8M-22.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.4M1.5M2.2M2.8M
 
 
 
 
 
Shares To Calculate EPS Diluted1.4M1.5M2.2M2.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$6.40-$6.40-$6.00-$7.89
 
 
 
 
 
EPS Diluted-$6.40-$6.40-$6.00-$7.89